# 137 cancer drugs capped at 30% trade margin from 9 Nov 2026-10-17T16:47:02+00:00 | Governance | Indian Opinion Desk Corroboration: 1 independent outlet The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has imposed a trade margin rationalisation (TMR) on 137 identified non-scheduled anti-cancer drugs, capping the margin at 30% of the maximum retail price (MRP). The move, notified in the gazette on 17 October 2026, is expected to cut MRPs by up to 70% on current prices, making cancer treatment more affordable. The list was recommended by an expert committee under the Directorate General of Health Services (DGHS) comprising oncologists, medical experts and government officials. The current exercise expands on a 2019 pilot that capped margins on 42 cancer drugs, which later led to MRP reductions of up to 90% on 526 brands. All manufacturers must report revised prices to NPPA within seven days of the gazette notification. The new prices take effect from 9 November 2026. Retailers and hospitals must sell at the lower rates from that date and display revised prices. State drug controllers will enforce compliance. ## Indian Opinion Analysis The price cap directly targets the high out-of-pocket expenditure that cancer patients face, particularly for non-scheduled drugs not already under price control. By fixing the trade margin at 30%, NPPA shifts the financial burden from patients to the supply chain. The effectiveness will depend on whether manufacturers maintain supply levels, as they are required to do. Hospitals that buy drugs directly must ensure the revised prices reach patients from 9 November 2026. ## Coverage - pib.gov.in Press release presents the move as a pro-patient relief measure This brief was synthesised by AI from the source linked above. Tags: Cancer drugs, Department of Pharmaceuticals, DGHS, NPPA Canonical: https://indianopinion.org/137-cancer-drugs-capped-at-30-trade-margin-from-9-nov/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/137-cancer-drugs-capped-at-30-trade-margin-from-9-nov/#story-in-brief How this brief was made: an AI model read the report linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/